Showing results (1631-1640 of 1,722) with videos related to

Sort By:
Pageof 173
Nano Letters|September 1, 2022
Controlling Nanoparticle Uptake in Innate Immune Cells with Heparosan PolysaccharidesWen Yang, Alex N Frickenstein, Vinit Sheth, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 22, 2026
The EPS-I exopolysaccharide transforms Ralstonia wilt pathogen biofilms into viscoelastic fluids for rapid dissemination in plantaMatthew L Cope-Arguello, Jiayu Li, Zachary Konkel, et al.
Diabetes|May 15, 2015
Forced Hepatic Overexpression of CEACAM1 Curtails Diet-Induced Insulin ResistanceQusai Y Al-Share, Anthony M DeAngelis, Sumona Ghosh Lester, et al.
Plos One|October 15, 2011
Influence of ROBO1 and RORA on risk of age-related macular degeneration reveals genetically distinct phenotypes in disease pathophysiologyGyungah Jun, Michael Nicolaou, Margaux A Morrison, et al.
Neuro-Oncology|January 20, 2026
Ibrutinib in combination with rituximab, methotrexate, vincristine, and procarbazine (R-MVP/i) for newly diagnosed primary CNS lymphoma (PCNSL)Lauren R Schaff, Elena Pentsova, Rachna Malani, et al.
International Journal of Radiation Oncology, Biology, Physics|October 12, 2010
A phase I trial of tipifarnib with radiation therapy, with and without temozolomide, for patients with newly diagnosed glioblastomaPhioanh Leia Nghiemphu, Patrick Y Wen, Kathleen R Lamborn, et al.
Neuro-Oncology|February 13, 2010
A phase I trial of erlotinib in patients with nonprogressive glioblastoma multiforme postradiation therapy, and recurrent malignant gliomas and meningiomasJeffrey J Raizer, Lauren E Abrey, Andrew B Lassman, et al.
Neuro-Oncology|October 27, 2012
Phase I/II study of sorafenib in combination with temsirolimus for recurrent glioblastoma or gliosarcoma: North American Brain Tumor Consortium study 05-02Eudocia Q Lee, John Kuhn, Kathleen R Lamborn, et al.
Vox Sanguinis|June 14, 2020
Guidance for the procurement of COVID-19 convalescent plasma: differences between high- and low-middle-income countriesEvan M Bloch, Ruchika Goel, Silvano Wendel, et al.
Blood|December 21, 2018
Phase 1b trial of an ibrutinib-based combination therapy in recurrent/refractory CNS lymphomaChristian Grommes, Sarah S Tang, Julia Wolfe, et al.
Pageof 173